The deal also alleviates two of my biggest concerns with going alone in 2020: commercialization and Samsung. On reason I mentioned the word we shall not say a few days ago, an A/S raise wouldn’t have been enough to get that done alone. Once bla is submitted and current mono trial is done, their monthly burn for 2020 is greatly reduced. With sp appreciation, gentle raises with milestones, we might actually see the demand for public stock higher than their need for selling private offerings for the first time ever.